Frontier relocating to new facility in Thousand Oaks
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Santa Barbara Inn project teaches lessons
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Dubroff: CLU’s Hub 101 bridging tech startup divide in Ventura County
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Our view: Dole Food layoffs loom over Ventura County
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Managers need to develop social capital
By Kapp Johnson You might be well aware of John Donne’s poem “No Man is an Island.” Written in 1674, it was not originally a poem but prose. It speaks profoundly of what we might call social capital today. The poem speaks beyond networking to a depth of relationships that are more than instrumental. In Read More →
Ridley-Tree Cancer Center in Santa Barbara celebrates grand opening
The Ridley-Tree Cancer Center celebrated its grand opening on Sept. 13 and its first patients will be treated Sept. 18, ushering in a new era of cancer treatment in Santa Barbara. “It has taken a small village of people over a decade to make this dream a reality,” said Kurt Ransohoff, CEO and chief medical Read More →
FDA approves Amgen cancer treatment biosimilar Mvasi
The U.S. Food and Drug Administration approved a cancer treatment biosimilar developed in partnership between Allergan and Thousand Oaks-based Amgen, the company announced Sept. 13. Mvasi was approved to treat five types of cancer in combination with other therapies. “The approval of Mvasi marks a significant milestone for healthcare practitioners and patients as the first Read More →
